Abstract

Background HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) is a chronic disabling disease caused by the retrovirus HTLV-1. It is a horrible, chronic, progressing disease causing weakness of lower limbs, bladder, bowel and erectile dysfunction, as well as pain in the lower back and legs. HAM/TSP is associated with significantly higher mortality and morbidity than the general population. Currently there is no cure or antiviral treatment for HTLV-1 and no internationally agreed treatment for patients with HAM/TSP. We had two aims: to identify the level of evidence of current medicinal treatment strategies available to patients and clinicians and to identify drugs that should be pursued for future clinical trials.

Highlights

  • HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) is a chronic disabling disease caused by the retrovirus HTLV-1

  • HAM/TSP is associated with significantly higher mortality and morbidity than the general population

  • We had two aims: to identify the level of evidence of current medicinal treatment strategies available to patients and clinicians and to identify drugs that should be pursued for future clinical trials

Read more

Summary

Background

HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) is a chronic disabling disease caused by the retrovirus HTLV-1. It is a horrible, chronic, progressing disease causing weakness of lower limbs, bladder, bowel and erectile dysfunction, as well as pain in the lower back and legs. HAM/TSP is associated with significantly higher mortality and morbidity than the general population. There is no cure or antiviral treatment for HTLV-1 and no internationally agreed treatment for patients with HAM/TSP. We had two aims: to identify the level of evidence of current medicinal treatment strategies available to patients and clinicians and to identify drugs that should be pursued for future clinical trials

Conclusions
Methods
Findings
Results
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.